Veracyte Accounts Payable vs Total Current Assets Analysis

VCYT Stock

USD 20.63 0.51 2.53%

Veracyte financial indicator trend analysis is much more than just breaking down Veracyte prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Veracyte is a good investment. Please check the relationship between Veracyte Accounts Payable and its Total Current Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Veracyte. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.

Accounts Payable vs Total Current Assets

Accounts Payable vs Total Current Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Veracyte Accounts Payable account and Total Current Assets. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Veracyte's Accounts Payable and Total Current Assets is 0.52. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of Veracyte, assuming nothing else is changed. The correlation between historical values of Veracyte's Accounts Payable and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Veracyte are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Accounts Payable i.e., Veracyte's Accounts Payable and Total Current Assets go up and down completely randomly.

Correlation Coefficient

0.52

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Accounts Payable

An accounting item on the balance sheet that represents Veracyte obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Veracyte are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Most indicators from Veracyte's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Veracyte current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Veracyte. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.At this time, Veracyte's Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 392.7 K in 2024, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	227.0M	236.0M	235.2M	247.0M
Cost Of Revenue	74.4M	101.6M	137.9M	144.8M

Total Operating Expenses Cost Of Revenue

Veracyte fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Property Plant Equipment
Total Assets		0.98	0.98	1.0	0.76	0.96	-0.68	-0.88	0.9	0.61	0.98	-0.5	0.3	0.63	0.98	0.9	0.84	0.49	0.95	0.84	0.99	0.94	0.88	0.72	0.8	0.96
Other Current Liab	0.98		1.0	0.98	0.74	0.95	-0.58	-0.85	0.95	0.51	0.99	-0.51	0.2	0.54	0.96	0.89	0.81	0.51	0.96	0.84	0.97	0.96	0.88	0.65	0.79	0.97
Total Current Liabilities	0.98	1.0		0.98	0.73	0.94	-0.57	-0.85	0.96	0.5	0.99	-0.51	0.18	0.53	0.96	0.88	0.8	0.49	0.96	0.84	0.97	0.95	0.88	0.64	0.78	0.97
Total Stockholder Equity	1.0	0.98	0.98		0.75	0.96	-0.68	-0.87	0.9	0.61	0.98	-0.5	0.3	0.63	0.97	0.89	0.84	0.48	0.94	0.84	0.99	0.93	0.88	0.73	0.8	0.96
Other Liab	0.76	0.74	0.73	0.75		0.81	-0.7	-0.73	0.61	0.74	0.7	-0.56	0.5	0.74	0.76	0.77	0.84	0.65	0.66	0.83	0.76	0.76	0.56	0.81	0.84	0.71
Property Plant And Equipment Net	0.96	0.95	0.94	0.96	0.81		-0.71	-0.94	0.85	0.66	0.93	-0.44	0.34	0.68	0.98	0.96	0.9	0.63	0.96	0.81	0.98	0.96	0.88	0.77	0.88	0.96
Net Debt	-0.68	-0.58	-0.57	-0.68	-0.7	-0.71		0.69	-0.48	-0.97	-0.54	0.11	-0.7	-0.97	-0.68	-0.77	-0.71	-0.41	-0.61	-0.46	-0.69	-0.59	-0.57	-0.94	-0.74	-0.56
Retained Earnings	-0.88	-0.85	-0.85	-0.87	-0.73	-0.94	0.69		-0.75	-0.65	-0.83	0.27	-0.34	-0.67	-0.94	-0.95	-0.92	-0.72	-0.91	-0.68	-0.94	-0.92	-0.86	-0.75	-0.87	-0.91
Accounts Payable	0.9	0.95	0.96	0.9	0.61	0.85	-0.48	-0.75		0.4	0.92	-0.43	0.07	0.42	0.87	0.82	0.68	0.42	0.92	0.76	0.89	0.9	0.85	0.52	0.7	0.91
Cash	0.61	0.51	0.5	0.61	0.74	0.66	-0.97	-0.65	0.4		0.46	-0.18	0.77	1.0	0.62	0.73	0.75	0.49	0.53	0.49	0.63	0.54	0.45	0.98	0.79	0.49
Non Current Assets Total	0.98	0.99	0.99	0.98	0.7	0.93	-0.54	-0.83	0.92	0.46		-0.54	0.17	0.49	0.95	0.84	0.79	0.45	0.93	0.86	0.96	0.93	0.87	0.6	0.73	0.96
Non Currrent Assets Other	-0.5	-0.51	-0.51	-0.5	-0.56	-0.44	0.11	0.27	-0.43	-0.18	-0.54		-0.37	-0.21	-0.42	-0.29	-0.49	-0.15	-0.3	-0.84	-0.44	-0.4	-0.08	-0.31	-0.45	-0.39
Other Assets	0.3	0.2	0.18	0.3	0.5	0.34	-0.7	-0.34	0.07	0.77	0.17	-0.37		0.79	0.29	0.38	0.53	0.21	0.16	0.35	0.32	0.19	-0.03	0.75	0.54	0.14
Cash And Short Term Investments	0.63	0.54	0.53	0.63	0.74	0.68	-0.97	-0.67	0.42	1.0	0.49	-0.21	0.79		0.64	0.74	0.77	0.48	0.55	0.51	0.65	0.56	0.46	0.99	0.81	0.51
Net Receivables	0.98	0.96	0.96	0.97	0.76	0.98	-0.68	-0.94	0.87	0.62	0.95	-0.42	0.29	0.64		0.95	0.89	0.62	0.97	0.8	0.99	0.97	0.9	0.74	0.85	0.97
Common Stock Total Equity	0.9	0.89	0.88	0.89	0.77	0.96	-0.77	-0.95	0.82	0.73	0.84	-0.29	0.38	0.74	0.95		0.88	0.72	0.93	0.7	0.94	0.95	0.86	0.81	0.92	0.91
Common Stock Shares Outstanding	0.84	0.81	0.8	0.84	0.84	0.9	-0.71	-0.92	0.68	0.75	0.79	-0.49	0.53	0.77	0.89	0.88		0.7	0.81	0.81	0.89	0.83	0.69	0.86	0.95	0.81
Non Current Liabilities Total	0.49	0.51	0.49	0.48	0.65	0.63	-0.41	-0.72	0.42	0.49	0.45	-0.15	0.21	0.48	0.62	0.72	0.7		0.57	0.49	0.57	0.71	0.53	0.55	0.77	0.6
Inventory	0.95	0.96	0.96	0.94	0.66	0.96	-0.61	-0.91	0.92	0.53	0.93	-0.3	0.16	0.55	0.97	0.93	0.81	0.57		0.7	0.96	0.96	0.95	0.65	0.8	0.97
Other Current Assets	0.84	0.84	0.84	0.84	0.83	0.81	-0.46	-0.68	0.76	0.49	0.86	-0.84	0.35	0.51	0.8	0.7	0.81	0.49	0.7		0.81	0.79	0.56	0.63	0.78	0.78
Other Stockholder Equity	0.99	0.97	0.97	0.99	0.76	0.98	-0.69	-0.94	0.89	0.63	0.96	-0.44	0.32	0.65	0.99	0.94	0.89	0.57	0.96	0.81		0.96	0.9	0.75	0.84	0.97
Total Liab	0.94	0.96	0.95	0.93	0.76	0.96	-0.59	-0.92	0.9	0.54	0.93	-0.4	0.19	0.56	0.97	0.95	0.83	0.71	0.96	0.79	0.96		0.9	0.66	0.84	0.98
Property Plant And Equipment Gross	0.88	0.88	0.88	0.88	0.56	0.88	-0.57	-0.86	0.85	0.45	0.87	-0.08	-0.03	0.46	0.9	0.86	0.69	0.53	0.95	0.56	0.9	0.9		0.54	0.65	0.94
Total Current Assets	0.72	0.65	0.64	0.73	0.81	0.77	-0.94	-0.75	0.52	0.98	0.6	-0.31	0.75	0.99	0.74	0.81	0.86	0.55	0.65	0.63	0.75	0.66	0.54		0.88	0.62
Common Stock	0.8	0.79	0.78	0.8	0.84	0.88	-0.74	-0.87	0.7	0.79	0.73	-0.45	0.54	0.81	0.85	0.92	0.95	0.77	0.8	0.78	0.84	0.84	0.65	0.88		0.78
Property Plant Equipment	0.96	0.97	0.97	0.96	0.71	0.96	-0.56	-0.91	0.91	0.49	0.96	-0.39	0.14	0.51	0.97	0.91	0.81	0.6	0.97	0.78	0.97	0.98	0.94	0.62	0.78

Click cells to compare fundamentals

Veracyte Account Relationship Matchups

Veracyte fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	275.2M	457.2M	1.2B	1.2B	1.1B	1.2B
Other Current Liab	13.7M	11.7M	42.4M	44.0M	41.2M	43.2M
Total Current Liabilities	17.5M	16.8M	64.2M	62.6M	61.2M	64.3M
Total Stockholder Equity	239.5M	421.2M	1.1B	1.1B	1.0B	1.1B
Other Liab	6.1M	8.4M	13.1M	7.6M	8.7M	5.6M
Property Plant And Equipment Net	17.7M	16.8M	31.1M	30.9M	30.9M	32.4M
Net Debt	(145.7M)	(337.0M)	(154.3M)	(139.5M)	(203.8M)	(193.6M)
Retained Earnings	(246.7M)	(281.6M)	(357.2M)	(393.7M)	(468.1M)	(444.7M)
Accounts Payable	2.3M	3.1M	12.4M	11.9M	12.9M	13.6M
Cash	159.3M	349.4M	173.2M	154.2M	216.5M	117.7M
Non Current Assets Total	87.5M	81.5M	944.7M	907.8M	852.2M	894.8M
Non Currrent Assets Other	2.0M	2.0M	(35.1M)	(26.8M)	6.0M	6.3M
Other Assets	2.0M	9.8M	2.9M	6.2M	1.0	0.95
Cash And Short Term Investments	159.3M	349.4M	173.2M	178.9M	216.5M	119.7M
Net Receivables	19.3M	18.5M	41.5M	44.0M	45.1M	47.3M
Common Stock Total Equity	50K	58K	71K	72K	82.8K	86.9K
Common Stock Shares Outstanding	46.1M	53.2M	67.9M	71.5M	72.6M	41.6M
Liabilities And Stockholders Equity	275.2M	457.2M	1.2B	1.2B	1.1B	1.2B
Non Current Liabilities Total	18.3M	19.2M	27.2M	18.6M	32.5M	19.6M
Inventory	6.8M	4.7M	11.2M	14.3M	16.1M	16.9M
Other Current Assets	2.2M	3.2M	17.2M	11.5M	8.0M	4.6M
Other Stockholder Equity	486.1M	702.8M	1.5B	1.5B	1.5B	1.6B
Total Liab	35.8M	35.9M	91.3M	81.2M	93.7M	98.4M
Property Plant And Equipment Gross	17.7M	9.0M	31.1M	30.9M	63.7M	66.9M
Total Current Assets	187.7M	375.7M	243.1M	248.6M	285.6M	148.7M
Accumulated Other Comprehensive Income	(12.0M)	0.0	(15.1M)	(31.3M)	(24.0M)	(22.8M)
Common Stock	50K	58K	71K	72K	73K	42.9K
Property Plant Equipment	8.9M	9.0M	31.1M	30.9M	35.5M	37.3M
Short Long Term Debt Total	13.6M	12.3M	18.9M	14.7M	12.6M	16.3M
Net Tangible Assets	171.7M	358.6M	185.9M	379.3M	436.2M	458.0M
Long Term Debt	25.2M	23.9M	694K	810K	931.5K	884.9K
Retained Earnings Total Equity	(246.7M)	(281.6M)	(357.2M)	(393.7M)	(354.3M)	(372.1M)
Long Term Debt Total	25.2M	23.9M	694K	810K	931.5K	884.9K
Capital Surpluse	486.1M	702.8M	1.5B	1.5B	1.7B	1.8B
Deferred Long Term Liab	4.2M	3.9M	5.6M	4.5M	5.2M	4.3M
Intangible Assets	65.0M	59.9M	202.7M	174.9M	88.6M	66.2M
Short Term Debt	1.4M	1.6M	4.8M	4.1M	5.1M	6.3M

Veracyte Investors Sentiment

The influence of Veracyte's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Veracyte. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Veracyte's public news can be used to forecast risks associated with an investment in Veracyte. The trend in average sentiment can be used to explain how an investor holding Veracyte can time the market purely based on public headlines and social activities around Veracyte. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Veracyte's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Veracyte's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Veracyte's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Veracyte.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Veracyte in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Veracyte's short interest history, or implied volatility extrapolated from Veracyte options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

IAUM	iShares Gold Trust
C	Citigroup
V	Visa Class A

When determining whether Veracyte is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Veracyte Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Veracyte Stock. Highlighted below are key reports to facilitate an investment decision about Veracyte Stock:

How To Invest In Veracyte

Details

Is Veracyte Stock a good investment?

Details

What is Veracyte's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Veracyte. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.

You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Veracyte Stock analysis

When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.

	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets

Is Veracyte's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Veracyte. If investors know Veracyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Veracyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.93)

Revenue Per Share

5.123

Quarterly Revenue Growth

0.175

Return On Assets

(0.01)

Return On Equity

(0.06)

The market value of Veracyte is measured differently than its book value, which is the value of Veracyte that is recorded on the company's balance sheet. Investors also form their own opinion of Veracyte's value that differs from its market value or its book value, called intrinsic value, which is Veracyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Veracyte's market value can be influenced by many factors that don't directly affect Veracyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Veracyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Veracyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Veracyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Veracyte Accounts Payable vs Total Current Assets Analysis

Accounts Payable vs Total Current Assets

Accounts Payable vs Total Current Assets Correlation Analysis

Correlation Coefficient

Accounts Payable

Total Current Assets

Veracyte fundamental ratios Correlations

Veracyte Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Veracyte fundamental ratios Accounts

Veracyte Investors Sentiment

Also Currently Popular

Complementary Tools for Veracyte Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Other Current Liab
Cash And Short Term Investments	+ 1.0	Cash
Other Stockholder Equity	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Other Current Liab
Non Current Assets Total	+ 0.99	Total Current Liabilities

Cash And Short Term Investments	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Common Stock Total Equity	- 0.95	Retained Earnings
Other Stockholder Equity	- 0.94	Retained Earnings
Net Receivables	- 0.94	Retained Earnings
Total Current Assets	- 0.94	Net Debt